Article Text

Download PDFPDF

P2.103 Differential Effect of Standard Therapies For Non-Gonococcal Urethritis Against Ureaplasma Species
  1. C M Khosropour1,
  2. L E Manhart1,
  3. C W Gillespie2,
  4. M Lowens3,
  5. M R Golden1,3,
  6. P A Totten1
  1. 1University of Washington, Seattle, WA, United States
  2. 2Children’s National Medical Center, Washington, DC, United States
  3. 3STD Program, Public Health - Seattle and King County, Seattle, WA, United States


Background U. urealyticum (UU) but not U. parvum (UP) is associated with non-gonococcal urethritis (NGU), while UP may be associated with adverse pregnancy outcomes. Treatment failure may differ byspecies; therefore, we examined the efficacy of CDC-recommended therapies for NGU against UU and UP separately.

Methods From May 2007 to July 2011, men aged ≥ 16 years attending an STD clinic in Seattle, Washington with NGU (urethral discharge or urethral symptoms plus ≥ 5 PMNs/HPF) were enrolled in a randomised treatment trial. Participants received active azithromycin (1g) and placebo doxycycline or active doxycycline (100 mg bid × 7d) and placebo azithromycin. Ureaplasma species were detected in broth urine culture followed by species-specific PCR. Microbiologic failure (detected by PCR) was determined at 3, 6, and 9 weeks. At 3 weeks, men who failed initial treatment received the alternate therapy (active doxycycline if they first received active azithromycin and vice versa). Persistent failures received moxifloxacin at 6 weeks.

Results Of 479 enrolled men, 107 (22.3%) and 59 (12.3%) were infected with UU and UP, respectively, and returned at 3 weeks. Among men who received azithromycin, microbiologic failure at 3 weeks occurred in 46.7% (14/30) of UP-infected men and 25.0% (13/52) of UU-infected men (P = 0.04). Among doxycycline-treated men, failure occurred in 24.1% (7/29) and 30.9% (17/55), respectively (P = 0.64). At 6 weeks, 80% (4/5) of UP and 58% (7/12) of UU-infected men originally treated with doxycycline and re-treated with azithromycin were failures; failure among men originally treated with azithromycin and re-treated with doxycycline was 57% (8/14) and 55% (6/11), respectively. At 9 weeks, failure after treatment with moxifloxacin occurred in 27.3% (3/11) of UP and 36.4% (4/11) of UU-infected men.

Conclusion Azithromycin was less effective against UP than UU. Failure after re-treatment with alternate therapy and moxifloxacin was common for both UU and UP.

  • Ureaplasma
  • Urethritis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.